You are here:
Publication details
Identifying CYP2D6 intermediate and poor metabolizers among schizophrenic patients with respect to therapeutical response.
Authors | |
---|---|
Year of publication | 2010 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | The study sumarizes the knowledge of the correlation of metabolic phenotype and genotype of CYP2D6 with the therapeutical response in first episode- schizphrenic patients treated with risperidone. |
Related projects: |